Endo 3Q Profit Falls On Indevus Buyout Costs
Endo Pharmaceuticals' 3rd-quarter profit dips on buyout costs; pain drugs drive revenue
08:07AM 10/29/09
FDA Extends Review Of Endo Drug By 3 Months
Endo Pharma says FDA extends review of testosterone injection to Dec. 2, from Sept. 2
04:48PM 09/02/09
Endo Says FDA Accepts Application For Nebido
Endo and Indevus say FDA aims to finish review of testosterone replacement Nebido by Sept. 2
12:07PM 03/12/09
Crucell Has Had Merger Talks With Wyeth
The company says the discussions are at a preliminary stage.
06:24PM 01/07/09
Yes, the Volatility of 2008 Was Record-Breaking (RealMoney.com $)
The fourth quarter alone had decades' worth of wild swings.
10:00AM 01/06/09
'Fast Money' Recap: A Risky Market for Investors
The trading panel says investors are in for risky market conditions in 2009.
07:25PM 01/05/09
Endo Pharma to Buy Indevus for $370M
Endo will acquire Indevus for $370 million, or $4.50 per share.
05:16PM 01/05/09
Health Winners & Losers: Indevus
Shares soar on a double dose of good news regarding an FDA ruling and a partnership with Teva Pharmaceuticals.
05:05PM 09/26/08
Indevus Soars on FDA, Partnership News (Update)
The stock rises after the biotech crosses an FDA hurdle for Nebido and a new partnership deal with Teva.
12:07PM 09/26/08
Indevus Soars on Improved FDA Timeline
The stock rises on news the biotech has crossed an FDA hurdle in its application for testosterone therapy Nebido.
10:47AM 09/26/08
Monday's Winners & Losers: Sirius
Shares are down 9.1% after the company announced financial guidance for the combined Sirius-XM Satellite Radio.
04:09PM 06/30/08
Health Winners & Losers: Myriad Genetics
Myriad Genetics sinks on Flurizan news.
04:04PM 06/30/08
Feuerstein's Biotech-Stock Mailbag: Delcath
More discussion of Sangamo's SB-509, revisiting Delcath and questioning YM Bio's chances with nimo.
10:03AM 06/27/08
Biotech-Stock Mailbag: Sangamo, YM Biosciences (RealMoney.com $)
More discussion of Sangamo's SB-509, revisiting Delcath and questioning YM Bio's chances with nimo.
07:03AM 06/27/08



Connect with TheStreet